Teva Inks $450m Deals Over US Kickback Claims, Including Alleged Copay Violations

 
• By Dean Rudge
  
Settlement newspaper headline on money
Teva is the seventh company to settle generic drug price fixing claims. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Pink Sheet